Miltenyi Biotec opens its new Nordic subsidiaryMiltenyi Biotec, a global provider of products and services for biomedical research and cellular therapy, announces today the opening of its newest subsidiary, Miltenyi Biotec Norden AB. Located in Lund, Sweden, Miltenyi Biotec Norden AB will service countries in the Nordic and Baltic regions, including Sweden, Denmark, Norway, Finland, Iceland, Lithuania, Latvia, and Estonia.
"We are very excited as we see great potential in the Nordic market, and together with our excellent team in place, I am confident that we will have a successful future in the region,” says Peter Norin, General Manager, Miltenyi Biotec Norden AB. “For all of our Nordic customers, both existing and future, this new location will mean better customer support, more convenient consultation, and a stronger business relationship.”
Miltenyi Biotec is one of the largest and most successful biotechnology companies in Germany, with more than 1,300 employees worldwide who develop, produce, and sell products and services used for biomedical research and cellular therapy.